Compounding Regulation Bill In Senate May Actually Encourage More Activity, Groups Argue

By Derrick Gingery / Email the Author / May 8, 2013 

Word Count: 1123 / Article # 14130508005 / Posted: May 8 2013 5:50 PM

---

Executive Summary

Some stakeholders worry that increased oversight of compounding may incentivize an expansion of the sector over traditional FDA-controlled manufacturing, but a compounding trade group thinks some provisions restrict prescriber ability to customize medications.

---

Purchase this Article

$50.00   BUY NOW

---

For $50.00, purchase this 1123-word articleand receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

LOG IN